β-blockers and modifiers of myocardial metabolism Flashcards
β-blockers used for angina
Atenolol
Nadolol
Propanolol
Metoprolol
β-blockers - contraindications
Variant angina, acute anginal attacks.
Heart failure.
Verapamil + β-blocker: significantly reduce cardiac output
β-blockers - MOA as antianginal drugs
Prevent exercise-induced tachycardia and myocardial oxygen demand. Prevent reflex tachycardia from vasodilators
β-blockers - benefits
Post-MI: improve survival
Drugs that modify myocardial metabolism
Ranolazine
Trimetazidine
Ranolazine - indications
Chronic stable angina
Ranolazine - MOA
Block pathologic activation/prolongation of late inward sodium current, which prevents excessive intracellular Na and Ca accumulation.
Reduces diastolic wall tension, improve diastolic subendocardial perfusion, reduce oxygen demand.
Ranolazine - effects
No effect on HR or blood pressure.
Increase exercise capacity.
Improve glycemic control and vascular endothelial function.
Decrease incidence of AF.
Ranolazine - adverse effects
Dizziness, headache, nausea, constipation.
Trimetazidine - MOA
Inhibits ketoacyl coenzyme-A thiolase, inhibiting β-oxidation of fatty acids. This shifts myocardial energy metabolism from fatty acids to glucose and reduce oxygen consumption.